Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity

Tissue Engineering - Part A

Volumn 20, Issue 15-16, 2014, Pages 2077-2087

  Suárez González, Darilis ^a   Lee, Jae Sung ^b   Diggs, Alisha ^c   Lu, Yan ^d   Nemke, Brett ^d   Markel, Mark ^d   Hollister, Scott J ^c   Murphy, William L ^a,b,e  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e AO FOUNDATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BLOOD VESSELS; BONE; COATINGS; HYDROGELS; MINERALS; REPAIR; TISSUE;

BETA TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; DOSE-DEPENDENT MANNER; FABRICATION TECHNIQUE; GROWTH FACTOR DELIVERY; INTRAMUSCULAR IMPLANTATION; RECOMBINANT HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR;

SCAFFOLDS (BIOLOGY);

BONE MORPHOGENETIC PROTEIN 2; MINERAL; RECOMBINANT VASCULOTROPIN; BETA-TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE TISSUE; CALCIUM PHOSPHATE CERAMIC; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPERIMENTAL SHEEP; FEMALE; IMPLANTATION; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING; TISSUE SCAFFOLD; ANIMAL; BONE; CHEMISTRY; DRUG EFFECTS; HUMAN; PHYSIOLOGY; PROCEDURES; PROSTHESIS IMPLANTATION; SHEEP;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CALCIUM PHOSPHATES; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PROSTHESIS IMPLANTATION; SHEEP; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84906572761     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0358     Document Type: Article

References (53)

1. Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnocchi, V., et al. Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells 24, 23, 2006.
2. Sieg, D.J., Hauck, C.R., Ilic, D., Klingbeil, C.K., Schaefer, E., Damsky, C.H., et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2, 249, 2000.
3. Suarez-Gonzalez, D., Lee, J.S., Lan Levengood, S.K., Vanderby, R., Jr., and Murphy, W.L. Mineral coatings modulate beta-TCP stability and enable growth factor binding and release. Acta Biomater 8, 1117, 2012.
4. Hanada, K., Dennis, J.E., and Caplan, A.I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrowderived mesenchymal stem cells. J Bone Miner Res 12, 1606, 1997.
5. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A 87, 2220, 1990.
6. van Beuningen, H.M., van der Kraan, P.M., Arntz, O.J., and van den Berg, W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71, 279, 1994.
7. Rosenblatt-Velin, N., Lepore, M.G., Cartoni, C., Beermann, F., and Pedrazzini, T. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J Clin Invest 115, 1724, 2005.
8. Hirano, S., Tateya, I., Kishimoto, Y., Kanemaru, S., and Ito, J. Clinical trial of regeneration of aged vocal folds with growth factor therapy. Laryngoscope 122, 327, 2012.
9. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
10. Kempen, D.H., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
11. Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., and Mooney, D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848, 2005.
12. Kim, J.H., Jung, Y., Kim, S.H., Sun, K., Choi, J., Kim, H.C., et al. The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-Assembling peptides. Biomaterials 32, 6080, 2011.
13. Liao, S.S., Guan, K., Cui, F.Z., Shi, S.S., and Sun, T.S. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model. Spine 28, 1954, 2003.
14. McKay, W.F., Peckham, S.M., and Badura, J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop 31, 729, 2007.
15. Edwards, R.B., 3rd, Seeherman, H.J., Bogdanske, J.J., Devitt, J., Vanderby, R., Jr., and Markel, M.D. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J Bone Joint Surg Am 86-A, 1425, 2004.
16. Kim, C.S., Kim, J.I., Kim, J., Choi, S.H., Chai, J.K., Kim, C.K., et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 26, 2501, 2005.
17. Aspenberg, P., and Turek, T. BMP-2 for intramuscular bone induction: Effect in squirrel monkeys is dependent on implantation site. Acta Orthop Scand 67, 3, 1996.
18. Jingushi, S., Urabe, K., Okazaki, K., Hirata, G., Sakai, A., Ikenoue, T., et al. Intramuscular bone induction by human recombinant bone morphogenetic protein-2 with betatricalcium phosphate as a carrier: In vivo bone banking for muscle-pedicle autograft. J Orthop Sci 7, 490, 2002.
19. Burkhardt, R., Kettner, G., Bohm, W., Schmidmeier, M., Schlag, R., Frisch, B., et al. Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: A comparative histomorphometric study. Bone 8, 157, 1987.
20. Carano, R.A., and Filvaroff, E.H. Angiogenesis and bone repair. Drug Discov Today 8, 980, 2003.
21. Glowacki, J. Angiogenesis in fracture repair. Clin Orthop Relat Res 355 Suppl, S82, 1998.
22. Maharaj, A.S., and D'Amore, P.A. Roles for VEGF in the adult. Microvasc Res 74, 100, 2007.
23. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161, 1163, 2003.
24. Ferrara, N., Gerber, H.P., and LeCouter, J. The biology of VEGF and its receptors. Nat Med 9, 669, 2003.
25. Bao, P., Kodra, A., Tomic-Canic, M., Golinko, M.S., Ehrlich, H.P., and Brem, H. The role of vascular endothelial growth factor in wound healing. J Surg Res 153, 347, 2009.
26. Ozawa, C.R., Banfi, A., Glazer, N.L., Thurston, G., Springer, M.L., Kraft, P.E., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113, 516, 2004.
27. Simons, M., and Ware, J.A. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2, 863, 2003.
28. Li, P., Ohtsuki, C., Kokubo, T., Nakanishi, K., Soga, N., Nakamura, T., and Yamamuro, T. Apatite formation induced by silica gel in a simulated body fluid. J Am Ceram Soc 75, 2094, 1992.
29. Habibovic, P. Biomimetic hydroxyapatite coating on metal implants. J Am Ceram Soc 85, 517, 2002.
30. Murphy, W.L., and Mooney, D.J. Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata. J Am Chem Soc 124, 1910, 2002.
31. Zhang, R., and Ma, P.X. Biomimetic polymer/apatite composite scaffolds for mineralized tissue engineering. Macromol Biosci 4, 100, 2004.
32. Zhang, Y., Ni, M., Zhang, M., and Ratner, B. Calcium phosphate-chitosan composite scaffolds for bone tissue engineering. Tissue Eng 9, 337, 2003.
33. Suarez-Gonzalez, D., Barnhart, K., Saito, E., Vanderby, R., Jr., Hollister, S.J., and Murphy, W.L. Controlled nucleation of hydroxyapatite on alginate scaffolds for stem cell-based bone tissue engineering. J Biomed Mater Res A 95, 222, 2010.
34. Suarez-Gonzalez, D., Barnhart, K., Migneco, F., Flanagan, C., Hollister, S.J., and Murphy, W.L. Controllable mineral coatings on PCL scaffolds as carriers for growth factor release. Biomaterials 33, 713, 2012.
35. Sohier, J., Daculsi, G., Sourice, S., de Groot, K., and Layrolle, P. Porous beta tricalcium phosphate scaffolds used as a BMP-2 delivery system for bone tissue engineering. J Biomed Mater Res Part A 92, 1105, 2010.
36. Saito, A., Suzuki, Y., Kitamura, M., Ogata, S., Yoshihara, Y., Masuda, S., et al. Repair of 20-mm long rabbit radial bone defects using BMP-derived peptide combined with an alphatricalcium phosphate scaffold. J Biomed Mater Res A 77, 700, 2006.
37. Saito, A., Suzuki, Y., Ogata, S., Ohtsuki, C., and Tanihara, M. Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res A 70, 115, 2004.
38. Lee, J.S., Wagoner Johnson, A.J., and Murphy, W.L. A modular, hydroxyapatite-binding version of vascular endothelial growth factor. Adv Mater 22, 5494, 2010.
39. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
40. Murphy, W.L., Simmons, C.A., Kaigler, D., and Mooney, D.J. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res 83, 204, 2004.
41. Lee, J.S., Suarez-Gonzalez, D., and Murphy, W.L. Mineral coatings for temporally controlled delivery of multiple proteins. Adv Mater 23, 4279, 2011.
42. Lee, J.S., Lee, J.S., and Murphy, W.L. Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfaces. Acta Biomater 6, 21, 2010.
43. Lee, J.S., Lee, J.S., Wagoner-Johnson, A., and Murphy, W.L. Modular peptide growth factors for substrate-mediated stem cell differentiation. Angew Chem Int Ed Engl 48, 6266, 2009.
44. Young, S., Patel, Z.S., Kretlow, J.D., Murphy, M.B., Mountziaris, P.M., Baggett, L.S., et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15, 2347, 2009.
45. Lu, Y., Markel, M.D., Nemke, B., Lee, J.S., Graf, B.K., and Murphy, W.L. Influence of hydroxyapatite-coated and growth factor-releasing interference screws on tendon-bone healing in an ovine model. Arthroscopy 25, 1427, 2009.
46. Lee, J.S., Lu, Y., Baer, G.S., Markel, M.D., and Murphy, W.L. Controllable protein delivery from coated surgical sutures. J Mater Chem 20, 8894, 2010.
47. Lu, Y., Lee, J.S., Nemke, B., Graf, B.K., Royalty, K., Illgen, R., 3rd, et al. Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model. PLoS One 7, e50378, 2012.
48. Jongpaiboonkit, L., Franklin-Ford, T., and Murphy, W.L. Growth of hydroxyapatite coatings on biodegradable polymer microspheres. ACS Appl Mater Interfaces 1, 1504, 2009.
49. Williams, J.M., Adewunmi, A., Schek, R.M., Flanagan, C.L., Krebsbach, P.H., Feinberg, S.E., et al. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 26, 4817, 2005.
50. Maus, U., Andereya, S., Gravius, S., Ohnsorge, J.A., Niedhart, C., and Siebert, C.H. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep. J Biomater Appl 22, 559, 2008.
51. Hollister, S.J., and Murphy, W.L. Scaffold translation: Barriers between concept and clinic. Tissue Eng Part B Rev 17, 459, 2011.
52. Cahill, K.S., Chi, J.H., Day, A., and Claus, E.B. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 302, 58, 2009.
53. Shields, L.B., Raque, G.H., Glassman, S.D., Campbell, M., Vitaz, T., Harpring, J., et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 31, 542, 2006.